Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
McGraw-Hill confirms a data exposure tied to a Salesforce misconfiguration as hackers claim 45M records, raising concerns over SaaS security risks. NTT Research launches Scale Academy to turn AI and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results